-
effectivehealthcare-admin.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
January 28, 2016 - (e.g., those who have
experienced prior treatment failures, who have advanced cirrhosis, who have renal … chronic HCV genotype
4 infection and for treating patients with chronic HCV genotype 1 infection with end-stage … renal disease on hemodialysis. … HCV genotype 4 infection and another for
treating chronic HCV genotype 1 infection in patients with end-stage … renal disease on hemodialysis.23
Merck submitted a new drug application for treating chronic HCV genotype
-
www.ahrq.gov/sites/default/files/wysiwyg/workingforquality/cms-quality-strategy.pdf
January 01, 2020 - Education does not end when a provider receives credentials or a patient
is discharged. … Value-Based Purchasing, patient-centered medical homes, Medicare Advantage Quality Bonus
Payments, and the End-Stage … Renal Disease Quality Incentive Program, CMS provides financial
incentives that reward providers for … CMS Quality Strategy 31
Summative Evaluation
Summative evaluation is conducted at the end of
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6Ngc3byQ9jeBy_pwyvD6or
September 01, 2014 - Ann Intern Med. 2014;161:336-346. doi:10.7326/M14-0530 www.annals.org
For author affiliations, see end … A high comorbid condition
level was defined as any end-stage disease, severe disability,
or 3 or more … nonfatal MI, per-
manent cranial nerve damage, pulmonary embolism, pneu-
monia, wound infection, acute renal … Effect
of hospital-level variation in the use of carotid artery stenting versus carotid end-
arterectomy … Carotid end-
arterectomy was performed with lower stroke and death rates than carotid artery
stenting
-
staging-meps.ahrq.gov/survey_comp/appendix_d_glossary.pdf
December 31, 2020 - Circumcision: Surgical removal of the end of the prepuce of the penis. … illnesses or injuries, or who require continued care for an ongoing illness that is not in an
acute stage … Deductible: The amount of money an insured person must pay “at the front end” before the
insurer will … Kidney
dialysis is used on patients with kidney (or renal) failure and may be carried out in the
hospital … Kidney dialysis is also
referred to as hemodialysis, dialysis, or renal dialysis.
-
staging-meps.ahrq.gov/survey_comp/appendix_d_glossary.shtml
December 31, 2020 - Circumcision: Surgical removal of the
end of the prepuce of the penis. … injuries, or who require continued care for an ongoing
illness that is not in an acute stage … Deductible: The amount of money an
insured person must pay “at the front end” … Kidney dialysis is used on
patients with kidney (or renal) failure and may be … Kidney dialysis is
also referred to as hemodialysis, dialysis, or renal
-
meps.ahrq.gov/survey_comp/appendix_d_glossary.shtml
December 31, 2020 - Circumcision: Surgical removal of the
end of the prepuce of the penis. … injuries, or who require continued care for an ongoing
illness that is not in an acute stage … Deductible: The amount of money an
insured person must pay “at the front end” … Kidney dialysis is used on
patients with kidney (or renal) failure and may be … Kidney dialysis is
also referred to as hemodialysis, dialysis, or renal
-
meps.ahrq.gov/survey_comp/appendix_d_glossary.pdf
December 31, 2020 - Circumcision: Surgical removal of the end of the prepuce of the penis. … illnesses or injuries, or who require continued care for an ongoing illness that is not in an
acute stage … Deductible: The amount of money an insured person must pay “at the front end” before the
insurer will … Kidney
dialysis is used on patients with kidney (or renal) failure and may be carried out in the
hospital … Kidney dialysis is also
referred to as hemodialysis, dialysis, or renal dialysis.
-
www.ahrq.gov/es/hai/patient-safety-resources/advances-in-hai/hai-article18.html
August 01, 2018 - Prevention and Control of HAIs
Preface
Advances in the Prevention and Control of HAIs: Setting the Stage … Common comorbidities included renal failure (23.5 percent), chronic lung disease (16.7 percent), paraplegia … steps involved time limitations as to when the process had to be completed to progress to the next stage
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
January 01, 2015 - you couldn't fiugre out which and
stratify by comparator
Correct, we have added text to clarify at end … and Brand
names of the FDA-approved members of the class, at
least those drugs available as of the end … Use of metformin in the setting of mildtomoderate
renal insufficiency. Diabetes Care. … Use
of metformin in the setting of mildtomoderate renal
insufficiency. … stage
renal disease)
a.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
January 01, 2015 - you couldn't fiugre out which and
stratify by comparator
Correct, we have added text to clarify at end … and Brand
names of the FDA-approved members of the class, at
least those drugs available as of the end … Use of metformin in the setting of mildtomoderate
renal insufficiency. Diabetes Care. … Use
of metformin in the setting of mildtomoderate renal
insufficiency. … stage
renal disease)
a.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-map-hcbs-draft-technical-brief.pdf
December 07, 2023 - Because of their role as end-users,
individuals with potential conflicts may be retained. … conditions, and people with specific conditions, most commonly Parkinson’s disease,
Alzheimer’s disease, or end-stage … conditions, and people with specific conditions,
most commonly Parkinson disease, Alzheimer disease, or end-stage … older adults with Parkinson’s
disease,53 dementia,33, 41, 42, 45, 46, 58 intellectual disabilities,50 end-stage … renal disease on home
dialysis,32, 38, 54 terminal illness,37 multiple chronic diseases,35, 39 or,
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGsDefManualV27Public.pdf
April 01, 2010 - such as significant
acute diseases, acute exacerbations of significant chronic diseases, advanced or end … stage chronic diseases, and chronic diseases associated with extensive debility. … To
this end, the severity assignment for APS-DRGs® has deviated from MS-DRGs in
several instances where … FOR OBESITY
637 DIABETES AGE 0-35
640 NUT & MISC METAB DIS AGE
656 KIDNEY&URETER PX/NEOPLSM
682 RENAL … 684 0-17 AGE SPLIT 682 RENAL FAILURE AGE>17
685 685 ADMIT FOR RENAL
-
hcup-us.ahrq.gov/db/nation/nis/APS_DRGsDefManualV26Public.pdf
April 01, 2010 - such as significant
acute diseases, acute exacerbations of significant chronic diseases, advanced or end … stage chronic diseases, and chronic diseases associated with extensive debility. … To
this end, the severity assignment for APS-DRGs® has deviated from MS-DRGs in
several instances where … FOR OBESITY
637 DIABETES AGE 0-35
640 NUT & MISC METAB DIS AGE
656 KIDNEY&URETER PX/NEOPLSM
682 RENAL … 684 0-17 AGE SPLIT 682 RENAL FAILURE AGE>17
685 685 ADMIT FOR RENAL
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary29/obstructive-sleep-apnea-in-adults-screening
November 15, 2022 - with mean baseline ESS scores of 10 or greater (indicating excessive daytime sleepiness) reported mean end … scores in the normal range of less than 10 142 , 143 for the positive airway pressure groups (mean end … Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 … study, only the findings from the first stage in which all patients were included are reported. m The … study, only the findings from the first stage in which all patients were included are reported.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/21264-Aparasu-draft-1.pdf
July 31, 2018 - The
cases were ascertained anytime between the start of follow-up (January 1, 2008) and study end date … The cases were ascertained anytime between the start of follow-up
(January 1, 2008) and study end date … occurrence of death in nursing home between the start of follow-
up (January 1, 2008) and the study end … used to manage end-of-life
symptoms, such as terminal respiratory secretions.68
Subgroup Analyses … dementia, cerebrovascular events, rheumatological
diseases, mild liver disease, pulmonary disorders, renal
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-01/aparasu-report.pdf
January 01, 2024 - The
cases were ascertained anytime between the start of follow-up (January 1, 2008) and study end date … The cases were ascertained anytime between the start of follow-up
(January 1, 2008) and study end date … occurrence of death in nursing home between the start of follow-
up (January 1, 2008) and the study end … used to manage end-of-life
symptoms, such as terminal respiratory secretions.68
Subgroup Analyses … dementia, cerebrovascular events, rheumatological
diseases, mild liver disease, pulmonary disorders, renal
-
www.ahrq.gov/sites/default/files/2024-01/aparasu-report.pdf
January 01, 2024 - The
cases were ascertained anytime between the start of follow-up (January 1, 2008) and study end date … The cases were ascertained anytime between the start of follow-up
(January 1, 2008) and study end date … occurrence of death in nursing home between the start of follow-
up (January 1, 2008) and the study end … used to manage end-of-life
symptoms, such as terminal respiratory secretions.68
Subgroup Analyses … dementia, cerebrovascular events, rheumatological
diseases, mild liver disease, pulmonary disorders, renal
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z6Rfj-qwfoMbuLp-hBmhzS
May 01, 2021 - Related article at
jamaotolaryngology.com
Author Affiliations: Author
affiliations are listed at the end … c Although this is a 2-stage study, only the findings from the first stage in which all patients were … mean baseline ESS
scores of 10 or greater (indicating excessive daytime sleepiness)
reported mean end … ESS scores in the normal range of less
than 10142,143 for the positive airway pressure groups (mean end … Renal sympathetic denervation in
patients with treatment-resistant hypertension (the
Symplicity HTN-2
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - also increases the risk of several
types of cancers including colorectal, endometrial, esophageal, renal … In December 2010, Arena Pharmaceuticals announced a plan to resubmit the lorcaserin NDA
by the end … phentermine plus topiramate combination is administered daily as an
oral medication.
15
In late-stage … treatment of obesity
this input, our overall assessment is that these interventions are in the higher end … Based on
this input, our overall assessment is that this intervention is in the lower end of the high
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - also increases the risk of several
types of cancers including colorectal, endometrial, esophageal, renal … In December 2010, Arena Pharmaceuticals announced a plan to resubmit the lorcaserin NDA
by the end … phentermine plus topiramate combination is administered daily as an
oral medication.
15
In late-stage … treatment of obesity
this input, our overall assessment is that these interventions are in the higher end … Based on
this input, our overall assessment is that this intervention is in the lower end of the high